Codexis, Inc. (4QK.F)
Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Stephen George Dilly MBBS, Ph.D. | President, CEO & Chairman | 1.15M | -- | 1960 |
Ms. Georgia L. Erbez | Chief Financial Officer | 455.49k | -- | 1967 |
Mr. Kevin Norrett M.B.A., M.S. | Chief Operating Officer | 642.81k | -- | 1973 |
Dr. Alison Moore Ph.D. | CTO & Executive VP | 518.62k | -- | 1967 |
Ms. Carrie McKim | Director of Investor Relations | -- | -- | -- |
Ms. Karen Frechou-Armijo | Senior VP & Head of Human Resources | -- | -- | -- |
Dr. Stefan Lutz Ph.D. | Senior Vice President of Research | -- | -- | -- |
Mr. John Schiffhauer | Senior Vice President of Intellectual Property | -- | -- | -- |
Codexis, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 188
Description
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Corporate Governance
Upcoming Events
May 14, 2025 at 8:00 PM UTC
Codexis, Inc. Earnings Date
Recent Events
Recent Events Information Not Available